HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $902,497 | +44.9% | 7,801 | +28.8% | 0.00% | 0.0% |
| Q2 2023 | $622,962 | -35.4% | 6,057 | -31.4% | 0.00% | 0.0% |
| Q1 2023 | $963,596 | -90.4% | 8,829 | -90.0% | 0.00% | -91.7% |
| Q4 2022 | $10,072,741 | -91.0% | 88,514 | -95.1% | 0.01% | -91.2% |
| Q3 2022 | $111,870,000 | -24.3% | 1,807,564 | -2.4% | 0.14% | -17.5% |
| Q2 2022 | $147,765,000 | -27.5% | 1,852,618 | -4.4% | 0.17% | +7.1% |
| Q1 2022 | $203,820,000 | +7.5% | 1,937,267 | +10.1% | 0.16% | -1.9% |
| Q4 2021 | $189,541,000 | +6.4% | 1,758,913 | +8.2% | 0.16% | +3.9% |
| Q3 2021 | $178,119,000 | +21.1% | 1,626,071 | +3.5% | 0.15% | +25.6% |
| Q2 2021 | $147,109,000 | +16770.3% | 1,571,013 | +16494.6% | 0.12% | +12000.0% |
| Q1 2021 | $872,000 | +25.8% | 9,467 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $693,000 | +8.1% | 9,467 | +14.7% | 0.00% | 0.0% |
| Q3 2020 | $641,000 | +39.7% | 8,257 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $459,000 | +66.9% | 8,257 | -11.2% | 0.00% | 0.0% |
| Q1 2020 | $275,000 | -18.4% | 9,300 | 0.0% | 0.00% | – |
| Q4 2019 | $337,000 | – | 9,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |